News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Atherotech Diagnostics Lab Release: VAP® Lipid Panel Demonstrates Value Of Cholesterol Subfraction Measurement In Heart Disease Treatment And Risk Assessment


11/19/2013 8:31:30 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

DALLAS--(BUSINESS WIRE)--Researchers using the Atherotech VAP® Lipid Panel demonstrated the comprehensive lipid profile’s value in heart disease treatment and risk assessment. Through measurement of HDL cholesterol subfractions and remnant lipoproteins, the VAP Lipid Panel was able to identify specific lipid disorders for personalized treatment that may lead to improved outcomes in two scientific abstracts presented today at the American Heart Association (AHA) Scientific Sessions 2013 in Dallas.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES